Dr. Mony Fraer, MD

Dr. Fraer practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Fraer's NPI, 1497845960, was assigned on October 13, 2006. Dr. Fraer holds Iowa license 38318.

Dr. Fraer's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Fraer's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Fraer is also affiliated with MercyOne Des Moines Medical Center. The medical group on file is Scanlan Center for School Mental Health Clinic. Dmand AI also links Dr. Fraer to 3 more hospitals and 2 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fraer practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Fraer's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Fraer's licenses on file in 2 states: Iowa and Arkansas.

CMS data shows 818 Medicare services from Dr. Fraer across 10 procedure codes in 2024, for 272 Medicare patients. Medicare paid $69,905 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 272 Medicare patients who saw Dr. Fraer in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 3.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fraer's median patient age at 63, with 40% women.

In 2024, Dr. Fraer wrote 745 Medicare Part D claims for 155 patients. 94% of them were for generic drugs. CMS names the drug for 562 of them, across 21 drugs with 11 or more claims each, at $21,148 in total drug cost. In 2023, CMS named 727 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Fraer for performance year 2024, reported as part of a group. Dr. Fraer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Fraer, published from 2015 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Renal Dialysis, Kidney Failure, Chronic and Decision Making. Dr. Fraer has published most often in PLoS One. Dr. Fraer's most frequent co-authors are Sarat C. Kuppachi, MD, Jayesh Patel, MD and Lisa M. Antes, MD.

CMS Open Payments shows 21 general payments to Dr. Fraer from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. ZOLL Medical Corporation paid the most, $1,295.